Jennison Associates
CELL

Jennison Associates’s PhenomeX Inc. Common Stock CELL Stock Holding History

Jennison Associates’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-41,720
Closed -$2.1M – 736
2021
Q1 		$2.1M Sell
41,720
-312
-0.7% -$21.3K ﹤0.01% 536
2020
Q4 		$3.76M Sell
42,032
-5,297
-11% -$446K ﹤0.01% 471
2020
Q3 		$3.61M Buy
+47,329
New +$3.01M ﹤0.01% 456

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates's CELL Position: Q2 2021 in Review

Jennison Associates sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2021, closing a stake of 41,720 shares — an estimated $2.1M sold.

Jennison Associates first reported a position in CELL in Q3 2020 and held it in 3 quarters. The position peaked at $3.76M in Q4 2020. 156 funds tracked by Wall St. Rank hold CELL as of Q2 2021.

  • Jennison Associates reported no remaining PhenomeX Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Jennison Associates sold 41,720 PhenomeX Inc. Common Stock shares in Q2 2021, an estimated $2.1M.
  • Jennison Associates first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Jennison Associates's PhenomeX Inc. Common Stock position peaked at $3.76M in Q4 2020.
  • 156 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2021.

Based on Jennison Associates's 13F filing for Q2 2021, filed 12 Aug 2021.